Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Romero

Showing results (1-10 of 715) with videos related to

Pageof 72
Sort By:
Medicina Clinica|September 8, 2022
Non-alcoholic steatohepatitisManuel Romero-Gómez
Metabolic Brain Disease|December 31, 2005
Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathyManuel Romero-Gómez
World Journal of Gastroenterology|November 30, 2006
Insulin resistance and hepatitis CManuel Romero-Gómez
Expert Opinion on Pharmacotherapy|April 14, 2010
Pharmacotherapy of hepatic encephalopathy in cirrhosisManuel Romero-Gómez
Revista Espanola De Enfermedades Digestivas|February 11, 2021
COVID-19 and the liver: the chicken or the egg dilemmaJavier Ampuero, Manuel Romero Gómez
Gastroenterologia Y Hepatologia|May 1, 2012
[Influence of non-alcoholic fatty liver disease on cardiovascular disease]Javier Ampuero, Manuel Romero-Gómez
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3Javier Ampuero, Manuel Romero-Gómez
Revista Espanola De Enfermedades Digestivas|February 12, 2021
Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet)Manuel Romero-Gómez, Javier Ampuero
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and managementGenoveva Berná, Manuel Romero-Gomez
World Journal of Hepatology|September 18, 2015
Assessing cardiovascular risk in hepatitis C: An unmet needJavier Ampuero, Manuel Romero-Gómez
Pageof 72

Showing results (1-10 of 715) with videos related to

Sort By:
Pageof 72
Medicina Clinica|September 8, 2022
Non-alcoholic steatohepatitisManuel Romero-Gómez
Metabolic Brain Disease|December 31, 2005
Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathyManuel Romero-Gómez
World Journal of Gastroenterology|November 30, 2006
Insulin resistance and hepatitis CManuel Romero-Gómez
Expert Opinion on Pharmacotherapy|April 14, 2010
Pharmacotherapy of hepatic encephalopathy in cirrhosisManuel Romero-Gómez
Revista Espanola De Enfermedades Digestivas|February 11, 2021
COVID-19 and the liver: the chicken or the egg dilemmaJavier Ampuero, Manuel Romero Gómez
Gastroenterologia Y Hepatologia|May 1, 2012
[Influence of non-alcoholic fatty liver disease on cardiovascular disease]Javier Ampuero, Manuel Romero-Gómez
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3Javier Ampuero, Manuel Romero-Gómez
Revista Espanola De Enfermedades Digestivas|February 12, 2021
Looking for a new name for non-alcoholic fatty liver disease in Spanish: esteatosis hepática metabólica (EHmet)Manuel Romero-Gómez, Javier Ampuero
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and managementGenoveva Berná, Manuel Romero-Gomez
World Journal of Hepatology|September 18, 2015
Assessing cardiovascular risk in hepatitis C: An unmet needJavier Ampuero, Manuel Romero-Gómez
Pageof 72